C12Y208/02014

PROBIOTIC SULFATION OF SECONDARY BILE ACIDS

The invention relates to a microbiome-based therapeutic composition comprising an engineered probiotic cell expressing a sulfotransferase and the use of the microbiome-based therapeutic composition in medicine and a therapeutic regimen.